RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins
- PMID: 15196911
- DOI: 10.1016/j.febslet.2004.04.087
RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins
Abstract
We studied the RNA aptamer Toggle-25/thrombin interaction during inhibition by antithrombin (AT), heparin cofactor II (HCII) and protein C inhibitor (PCI). Thrombin inhibition was reduced 3-fold by Toggle-25 for AT and HCII, but it was slightly enhanced for PCI. In the presence of glycosaminoglycans, AT and PCI had significantly reduced thrombin inhibition with Toggle-25, but it was only reduced 3-fold for HCII. This suggested that the primary effect of aptamer binding was through the heparin-binding site of thrombin, anion-binding exosite-2 (exosite-2). We localized the Toggle-25 binding site to Arg 98, Glu 169, Lys 174, Asp 175, Arg 245, and Lys 248 of exosite-2. We conclude that a RNA aptamer to thrombin exosite-2 might provide an effective clinical reagent to control heparin's anticoagulant action.
Similar articles
-
Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.Arch Biochem Biophys. 1998 Jul 1;355(1):101-8. doi: 10.1006/abbi.1998.0716. Arch Biochem Biophys. 1998. PMID: 9647672
-
Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.J Protein Chem. 1993 Dec;12(6):677-88. doi: 10.1007/BF01024926. J Protein Chem. 1993. PMID: 8136018
-
Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.J Biol Chem. 1994 Dec 30;269(52):32747-51. J Biol Chem. 1994. PMID: 7806495
-
General features of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitor.Blood Coagul Fibrinolysis. 1993 Jun;4(3):479-90. doi: 10.1097/00001721-199306000-00013. Blood Coagul Fibrinolysis. 1993. PMID: 8392392 Review.
-
Heparin cofactor II modulates the response to vascular injury.Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):454-60. doi: 10.1161/01.ATV.0000256471.22437.88. Epub 2006 Dec 28. Arterioscler Thromb Vasc Biol. 2007. PMID: 17194895 Review.
Cited by
-
Single-round isolation of diverse RNA aptamers from a random sequence pool.Biol Methods Protoc. 2018 May 24;3(1):bpy004. doi: 10.1093/biomethods/bpy004. eCollection 2018. Biol Methods Protoc. 2018. PMID: 32161798 Free PMC article.
-
Molecular recognition elements: DNA/RNA-aptamers to proteins.Biochem Mosc Suppl B Biomed Chem. 2010;4(2):138-149. doi: 10.1134/S1990750810020046. Epub 2010 May 23. Biochem Mosc Suppl B Biomed Chem. 2010. PMID: 32288940 Free PMC article. Review.
-
Rapid molecular imaging of active thrombi in vivo using aptamer-antidote probes.Mol Ther Nucleic Acids. 2023 Jan 21;31:440-451. doi: 10.1016/j.omtn.2023.01.009. eCollection 2023 Mar 14. Mol Ther Nucleic Acids. 2023. PMID: 36817726 Free PMC article.
-
Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine.J Cardiovasc Transl Res. 2010 Dec;3(6):704-16. doi: 10.1007/s12265-010-9230-6. Epub 2010 Nov 16. J Cardiovasc Transl Res. 2010. PMID: 21080135 Review.
-
Overview of the Therapeutic Potential of Aptamers Targeting Coagulation Factors.Int J Mol Sci. 2021 Apr 9;22(8):3897. doi: 10.3390/ijms22083897. Int J Mol Sci. 2021. PMID: 33918821 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous